4/A: AIM ImmunoTech Director Acquires Shares in Lieu of Compensation

William M Mitchell, a director at AIM ImmunoTech Inc., acquired 27,412 shares of common stock in lieu of director compensation.

Summary

• On January 15, 2025, William M Mitchell, a director of AIM ImmunoTech Inc., acquired 27,412 shares of common stock.
• The shares were acquired at a price of $0.19 per share.
• These shares were issued in lieu of director compensation under the company's Cash Conservation Plan.
• Following the transaction, Mitchell directly owns 172,266 shares of AIM ImmunoTech Inc.
• Mitchell also indirectly owns shares through a spouse and trusts, though the exact quantities are not specified in this filing.
• This Form 4/A is an amendment to correct a previous filing, changing a disposal to an acquisition.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as a director is increasing their stake in the company, signaling confidence. However, it's also in lieu of cash compensation, which could indicate cash constraints.

Positives

• A director taking shares in lieu of cash compensation demonstrates confidence in the company's future.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's prospects. A director accepting shares in lieu of cash compensation can be seen as a positive signal.

Stakeholder Impact

• Shareholders may view the director's increased stake as a positive sign.
• The Cash Conservation Plan may impact employees if it involves similar compensation adjustments.

Key Dates

Keywords

AIM ImmunoTech, Director, Share Acquisition, Form 4, Compensation, Mitchell, Insider Trading